Among patients with breast cancer who were under treatment of coenzyme Q10 (100 mg/day) and vitamin B group (riboflavin 10 mg and niacin 50 mg), inflammatory markers included TNF-α, IL-8, IL-6, IL-1β were significantly decreased (24). This evidence concerns the gene IL6 and breast cancer.